Michele Treglia
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Michele Treglia has a total of 266 co-authors. Here are the top co-authors by number of shared publications:
- Margherita Pallocci
Department of Life Sciences, Health and Health Professions, Link Campus University, 00165 Rome, Italy
16 shared publications - Luigi Tonino Marsella
University of Roma Tor Vergata, Italy
13 shared publications - Rossana Cecchi
Institute of Legal Medicine, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy
12 shared publications - Jessika Camatti
Department of Medicine and Surgery, University of Parma, Parma, Italy
11 shared publications - Pierluigi Passalacqua
Department of Public Health and Infectious Diseases, “Sapienza” University of Rome, 00185 Rome, Italy
11 shared publications - Douglas H. Ubelaker
Department of Anthropology, National Museum of Natural History, Smithsonian Institution, Washington, DC, USA
10 shared publications
Latest Publications
- Open Access
- 4 November 2026
- Published by MDPI AG in Healthcare
- Vol. 14 (21) , 3760
Artificial Intelligence in Gynecology and Obstetrics: Medico-Legal, Ethical, and Governance Challenges—A Narrative Review
Background: Artificial intelligence (AI) is entering gynecologic and obstetric imaging, risk prediction, decision support, robotic surgery, remote monitoring, and patient communication. An estimated 260,000 maternal deaths occurred worldwide in 2023, and in England obstetric claims account for 11% of clinical negligence claims but 55% of their value. AI errors, bias, or opacity in this specialty therefore carry major clinical and legal consequences. Objective: To synthesize the principal medico-legal and bioethical challenges associated with AI in gynecology and obstetrics and to propose a lifecycle governance framework for responsible clinical adoption. Methods: A narrative review with thematic synthesis was conducted. PubMed, Scopus, and Google Scholar were searched for records published from January 2020 to August 2026, supplemented by citation chaining and official legal databases. Two reviewers screened 131 records against predefined eligibility criteria; 41 sources (36 publications and 5 legal instruments) were included and analyzed thematically. Selection is reported in a PRISMA-style flow diagram. Results: Six connected risk domains were derived from five prespecified themes, namely validation and generalizability; professional competence and automation bias; distributed liability and evidentiary opacity; informed consent and patient autonomy; privacy and cybersecurity of reproductive data; and discrimination, access, and reproductive justice. Generative AI adds risks of hallucination, non-reproducibility, persuasive framing, and undocumented use. Existing law does not eliminate clinician responsibility: accountability is shared across developers, institutions, and professionals, but clinical judgment and documented oversight remain central. In the European Union, Medical Device Regulation and GDPR obligations already apply, whereas AI Act requirements for AI-enabled medical devices apply from August 2028 and the revised Product Liability Directive covers products placed on the market after 9 December 2026; causation and professional fault remain governed by national law. Conclusions: Safe adoption requires more than technical accuracy. We translate the findings into seven actionable institutional requirements, namely accountable ownership, minimum local validation, role-specific training, auditable documentation, equity monitoring, post-deployment surveillance, and incident reporting. AI should augment—not displace—clinically accountable and relational care.
- 4 November 2026
- Published by MDPI AG in Healthcare
- Vol. 14 (21) , 3760
Open AccessArtificial Intelligence in Gynecology and Obstetrics: Medico-Legal, Ethical, and Governance Challenges—A Narrative Review
Background: Artificial intelligence (AI) is entering gynecologic and obstetric imaging, risk prediction, decision support, robotic surgery, remote monitoring, and patient communication. An estimated 260,000 maternal deaths occurred worldwide in 2023, and in England obstetric claims account for 11% of clinical negligence claims but 55% of their value. AI errors, bias, or opacity in this specialty therefore carry major clinical and legal consequences. Objective: To synthesize the principal medico-legal and bioethical challenges associated with AI in gynecology and obstetrics and to propose a lifecycle governance framework for responsible clinical adoption. Methods: A narrative review with thematic synthesis was conducted. PubMed, Scopus, and Google Scholar were searched for records published from January 2020 to August 2026, supplemented by citation chaining and official legal databases. Two reviewers screened 131 records against predefined eligibility criteria; 41 sources (36 publications and 5 legal instruments) were included and analyzed thematically. Selection is reported in a PRISMA-style flow diagram. Results: Six connected risk domains were derived from five prespecified themes, namely validation and generalizability; professional competence and automation bias; distributed liability and evidentiary opacity; informed consent and patient autonomy; privacy and cybersecurity of reproductive data; and discrimination, access, and reproductive justice. Generative AI adds risks of hallucination, non-reproducibility, persuasive framing, and undocumented use. Existing law does not eliminate clinician responsibility: accountability is shared across developers, institutions, and professionals, but clinical judgment and documented oversight remain central. In the European Union, Medical Device Regulation and GDPR obligations already apply, whereas AI Act requirements for AI-enabled medical devices apply from August 2028 and the revised Product Liability Directive covers products placed on the market after 9 December 2026; causation and professional fault remain governed by national law. Conclusions: Safe adoption requires more than technical accuracy. We translate the findings into seven actionable institutional requirements, namely accountable ownership, minimum local validation, role-specific training, auditable documentation, equity monitoring, post-deployment surveillance, and incident reporting. AI should augment—not displace—clinically accountable and relational care.
- Open Access
- 19 February 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (4) , 1988
Paired-Box (PAX) Gene Signatures as a Biomarker of Breast Cancer Progression
Breast cancer is the leading cause of cancer-related death in women, and despite advances in preventive screening as well as in molecular classification, many patients still do not benefit from existing therapies, highlighting the importance of identifying new molecular determinants of treatment resistance. The Paired-box (PAX) family of developmental transcription factors are central regulators of tissue morphogenesis and lineage specification, yet their reactivation in tumors and contribution to breast cancer progression remain only partially defined. Here, a multi-level analysis integrating RNA sequencing and protein profiling in twenty-one primary breast carcinomas shows that distinct PAX members are directly correlated to distinct fundamental cancer hallmarks, including proliferation, cell death, epithelial–mesenchymal transition, immune evasion, and genomic instability. Specifically, PAX1 and PAX9 correlates with both cell death and proliferative markers, indicating dual roles in the regulation of cell fate. PAX1 and PAX9 correlate with both proliferative and apoptotic markers, indicating dual roles in cell fate regulation. PAX3, PAX5, and PAX8 are mainly associated with immune checkpoint expression, including PD-L1 and TIGIT, while PAX6 is linked to microsatellite instability and tumor mutational burden, implicating it in genomic dysregulation. Therefore, PAX-based molecular signatures identify that accurately predict lymph node metastasis at transcriptomic (PAX2–PAX7) levels. These findings establish PAX transcription factors as key modulators of breast cancer biology and support their potential as clinically relevant biomarkers for prognostic refinement and therapeutic stratification.
- 19 February 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (4) , 1988
Open AccessPaired-Box (PAX) Gene Signatures as a Biomarker of Breast Cancer Progression
Breast cancer is the leading cause of cancer-related death in women, and despite advances in preventive screening as well as in molecular classification, many patients still do not benefit from existing therapies, highlighting the importance of identifying new molecular determinants of treatment resistance. The Paired-box (PAX) family of developmental transcription factors are central regulators of tissue morphogenesis and lineage specification, yet their reactivation in tumors and contribution to breast cancer progression remain only partially defined. Here, a multi-level analysis integrating RNA sequencing and protein profiling in twenty-one primary breast carcinomas shows that distinct PAX members are directly correlated to distinct fundamental cancer hallmarks, including proliferation, cell death, epithelial–mesenchymal transition, immune evasion, and genomic instability. Specifically, PAX1 and PAX9 correlates with both cell death and proliferative markers, indicating dual roles in the regulation of cell fate. PAX1 and PAX9 correlate with both proliferative and apoptotic markers, indicating dual roles in cell fate regulation. PAX3, PAX5, and PAX8 are mainly associated with immune checkpoint expression, including PD-L1 and TIGIT, while PAX6 is linked to microsatellite instability and tumor mutational burden, implicating it in genomic dysregulation. Therefore, PAX-based molecular signatures identify that accurately predict lymph node metastasis at transcriptomic (PAX2–PAX7) levels. These findings establish PAX transcription factors as key modulators of breast cancer biology and support their potential as clinically relevant biomarkers for prognostic refinement and therapeutic stratification.
- Open Access
- 11 February 2026
- Published by Elsevier in Legal Medicine
- Vol. 82, 102808
Forensic age progression for missing person investigations: A pilot evaluation of recognition accuracy
- 11 February 2026
- Published by Elsevier in Legal Medicine
- Vol. 82, 102808
Open AccessForensic age progression for missing person investigations: A pilot evaluation of recognition accuracy
- Open Access
- 8 December 2025
- Published by Springer Nature in Biology Direct
- Vol. 21 (1)
Effect of pesticides on breast cancer tumor
Breast cancer is the most common malignancy among women worldwide. Increasing evidence suggests that chronic exposure to pesticides, many of which act as e
- 8 December 2025
- Published by Springer Nature in Biology Direct
- Vol. 21 (1)
Open AccessEffect of pesticides on breast cancer tumor
Breast cancer is the most common malignancy among women worldwide. Increasing evidence suggests that chronic exposure to pesticides, many of which act as e
- Open Access
- 10 October 2025
- Published by Elsevier in Legal Medicine
- Vol. 79, 102731
Testing age progression technique: evaluation of reliability and accuracy
- 10 October 2025
- Published by Elsevier in Legal Medicine
- Vol. 79, 102731
Open AccessTesting age progression technique: evaluation of reliability and accuracy
- Open Access
- 16 September 2025
- Published by Elsevier in Legal Medicine
- Vol. 78, 102708
A nationwide forensic case-series of femicides in Italy – Part 2: Clues to its epidemiology, prediction and prevention
- 16 September 2025
- Published by Elsevier in Legal Medicine
- Vol. 78, 102708
Open AccessA nationwide forensic case-series of femicides in Italy – Part 2: Clues to its epidemiology, prediction and prevention
- Open Access
- 5 September 2025
- Published by Elsevier in Legal Medicine
- Vol. 78, 102703
A nationwide forensic case-series of femicides in Italy – Part 1: Clues to the motives of the murder
- 5 September 2025
- Published by Elsevier in Legal Medicine
- Vol. 78, 102703
Open AccessA nationwide forensic case-series of femicides in Italy – Part 1: Clues to the motives of the murder
- Open Access
- 5 September 2025
- Published by MDPI AG in Forensic Sciences
- Vol. 5 (3) , 42
Sodium Nitrite-Related Fatalities: Are We Facing a New Trend? Case Report and Literature Review
Suicide is a public health concern worldwide. The methods used worldwide can vary based on geographical context and the ease with which victims can find the means to act on suicidal thoughts. In this context, the recent emergence of an online market for toxic and narcotic substances has increased accessibility to these substances for recreational and suicidal purposes. The presented case concerns a fatal sodium nitrite dose purchased online. The body exhibited the characteristic blue-gray staining of hypostasis, more evident on the neck and the upper third of the posterior surface of the chest, and toxicological analysis revealed methemoglobin levels exceeding 30%. Although there is no standardized analytical procedure, the determination of nitrite in postmortem samples is crucial in these cases. Additionally, nitrite is difficult to detect postmortem because it rapidly turns into sodium nitrate. In the case presented, capillary ion analysis (CIA) with direct UV detection was performed for the qualitative and quantitative determination of nitrite and nitrate in the cadaveric central blood samples. The analytical determination identified the presence of nitrite ions and sodium nitrate, in a concentration of 9515 µmol/L.
- 5 September 2025
- Published by MDPI AG in Forensic Sciences
- Vol. 5 (3) , 42
Open AccessSodium Nitrite-Related Fatalities: Are We Facing a New Trend? Case Report and Literature Review
Suicide is a public health concern worldwide. The methods used worldwide can vary based on geographical context and the ease with which victims can find the means to act on suicidal thoughts. In this context, the recent emergence of an online market for toxic and narcotic substances has increased accessibility to these substances for recreational and suicidal purposes. The presented case concerns a fatal sodium nitrite dose purchased online. The body exhibited the characteristic blue-gray staining of hypostasis, more evident on the neck and the upper third of the posterior surface of the chest, and toxicological analysis revealed methemoglobin levels exceeding 30%. Although there is no standardized analytical procedure, the determination of nitrite in postmortem samples is crucial in these cases. Additionally, nitrite is difficult to detect postmortem because it rapidly turns into sodium nitrate. In the case presented, capillary ion analysis (CIA) with direct UV detection was performed for the qualitative and quantitative determination of nitrite and nitrate in the cadaveric central blood samples. The analytical determination identified the presence of nitrite ions and sodium nitrate, in a concentration of 9515 µmol/L.
- Open Access
- 7 August 2025
- Published by Elsevier in Journal of Forensic and Legal Medicine
- Vol. 115, 102944
Artificial Intelligence in Forensic Neuropathology: A Systematic Review
- 7 August 2025
- Published by Elsevier in Journal of Forensic and Legal Medicine
- Vol. 115, 102944
Open AccessArtificial Intelligence in Forensic Neuropathology: A Systematic Review
- Open Access
The Crime of Vehicular Homicide in Italy: Trends in Alcohol and Drug Use in Fatal Road Accidents in Lazio Region from 2018 to 2024
In Italy, the law on road homicide (Law no. 41/2016) introduced specific provisions for drivers who cause severe injuries or death to a person due to the violation of the Highway Code. The use of alcohol or drugs while driving constitutes an aggravating circumstance of the offence and provides for a tightening of penalties. Our study aims to report on the analysis performed on blood samples collected between January 2018 and December 2024 from drivers convicted of road homicide and who tested positive for alcohol and/or drugs. The majority of the involved subjects were males belonging to the 18–30 and 41–50 age groups. Alcohol, cocaine and cannabinoids were the most detected substances and the most frequent polydrug combination was alcohol and cocaine. We also investigated other influencing factors in road traffic accidents as the day of the week and the time of the day in which fatal road traffic accident occurred, and the time elapsed between the road accident and the collection of biological samples. Our data, in line with the international scenario, strongly support that, in addition to the tightening of penalties, raising awareness plays a key role in preventing alcohol- and drug-related traffic accidents by increasing risk perception and encouraging safer driving behaviors.
Open AccessThe Crime of Vehicular Homicide in Italy: Trends in Alcohol and Drug Use in Fatal Road Accidents in Lazio Region from 2018 to 2024
In Italy, the law on road homicide (Law no. 41/2016) introduced specific provisions for drivers who cause severe injuries or death to a person due to the violation of the Highway Code. The use of alcohol or drugs while driving constitutes an aggravating circumstance of the offence and provides for a tightening of penalties. Our study aims to report on the analysis performed on blood samples collected between January 2018 and December 2024 from drivers convicted of road homicide and who tested positive for alcohol and/or drugs. The majority of the involved subjects were males belonging to the 18–30 and 41–50 age groups. Alcohol, cocaine and cannabinoids were the most detected substances and the most frequent polydrug combination was alcohol and cocaine. We also investigated other influencing factors in road traffic accidents as the day of the week and the time of the day in which fatal road traffic accident occurred, and the time elapsed between the road accident and the collection of biological samples. Our data, in line with the international scenario, strongly support that, in addition to the tightening of penalties, raising awareness plays a key role in preventing alcohol- and drug-related traffic accidents by increasing risk perception and encouraging safer driving behaviors.